Ringo: Discordance between the molecular and clinical manifestation in a Golden Retriever Muscular Dystrophy dog

Neuromuscular Disorders

Volumn 20, Issue 1, 2010, Pages 64-70

  Zucconi, Eder ^a   Valadares, Marcos Costa ^a   Vieira, Natássia M ^a   Bueno Jr , Carlos R ^a   Secco, Mariane ^a   Jazedje, Tatiana ^a   Almeida da Silva, Helga Cristina ^b   Vainzof, Mariz ^a   Zatz, Mayana ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Duchenne Muscular Dystrophy; Dystrophin; Golden Retriever Muscular Dystrophy; Mild phenotype

Indexed keywords

DYSTROPHIN; UTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOG; FEMALE; GENE MUTATION; GENETIC DISORDER; MALE; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BRAZIL; DISEASE PROGRESSION; DOGS; DYSTROPHIN; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUTATION; PEDIGREE; PHENOTYPE; SARCOGLYCANS; SEVERITY OF ILLNESS INDEX; SPECIES SPECIFICITY; UTROPHIN;

EID: 74149093235     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2009.10.011     Document Type: Article

References (21)

1. Hoffman E.P., Brown Jr. R.H., and Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51 (1987) 919-928
2. Emery A.E. The muscular dystrophies. Lancet 359 (2002) 687-695
3. Sharp N.J.H., Kornegay S.D., Van Camp S.D., et al. An error in dystrophin mRNA processing in Golden Retriever Muscular Dystrophy, an animal homologue of Duchenne Muscular Dystrophy. Genomics 13 (1992) 115-121
4. Ambrosio C.E., Valadares M.C., Zucconi E., et al. Ringo, a Golden Retriever Muscular Dystrophy (GRMD) dog with absent dystrophin but normal strength. Neuromuscul Disord 18 (2008) 892-893
5. Honeyman K., Carville K.S., Howell J.M., et al. Development of a snapback method of single-strand conformation polymorphism analysis for genotyping Golden Retrievers for the X-linked muscular dystrophy allele. Am J Vet Res 6 (1999) 734-737
6. Kennel P.F., Fonteneau P., Martin E., et al. Electromyographical and motor performance studies in the pmn mouse model of neurodegenerative disease. Neurobiol Dis 3 (1996) 137-147
7. Vieira N.M., Bueno Jr. C.R., Brandalise V., et al. Sjl dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression. Stem Cells 26 9 (2008) 2391-2398
8. Dubowitz V. Muscle biopsy: a practical approach (1985), Bailliere Tindall, London
9. Vainzof M., Passos-Bueno M.R., and Zatz M. Immunological methods for the analysis of protein expression in neuromuscular diseases. Methods Mol Biol 217 (2003) 355-378
10. Bulfield G., Siller W.G., Wight P.A., et al. X chromosome-linked dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81 (1984) 1189-1192
11. Dubowitz V. Enigmatic conflict of clinical and molecular diagnosis in Duchenne/Becker muscular dystrophy. Neuromuscul Disord 16 (2006) 865-866
12. Nicholson L.V., Davison K., Johnson M.A., et al. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci 94 (1989) 137-146
13. Dell'Agnola C., Wang Z., Storb R., et al. Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs. Blood 104 (2004) 4311-4318
14. Vainzof M., Pavanello R.C., Pavanello I., et al. Dystrophin immunofluorescence pattern in manifesting and asymptomatic carriers of Duchenne's and Becker muscular dystrophies of different ages. Neuromuscul Disord 1 (1991) 177-183
15. Fanin M., Danieli G.A., Vitiello L., et al. Prevalence of dystrophin-positive fibers in 85 Duchenne muscular dystrophy patients. Neuromuscul Disord 2 (1992) 41-45
16. Tinsley J.M., and Davies K.E. Utrophin: a potential replacement for dystrophin?. Neuromuscul Disord 3 (1993) 537-539
17. Cerletti M., Negri T., and Cozzi F. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Ther 10 (2003) 750-757
18. Sampaolesi M., Blot S., D'Antona G., et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444 (2006) 574-579
19. Bretag A.H. Too much hype, not enough hope: are balanced reporting and proper controls too much to expect from therapeutic studies in animal models of neuromuscular diseases that presage clinical trials in humans?. Neuromuscul Disord 16 (2007) 203-205
20. Grounds M.D., and Davies K.E. The allure of stem cell therapy for muscular dystrophy. Neuromuscul Disord 17 (2007) 206-208
21. Bretag A.H. Stem cell treatment of dystrophic dogs. Nature 450 (2007) E23